Lung Cancer
The Pharmacy Times® Lung Cancer Resource Center is a comprehensive resource for clinical news and expert insights on issues related to cancer that begins on the lungs, including non-small cell lung cancer and small cell lung cancer.
Latest News
September 17th 2025
Cemiplimab was also superior in improving progression-free survival, objective response rate, and duration of response in patients with non–small cell lung cancer (NSCLC).
More News
FDA Grants Breakthrough Designation to Tiragolumab Plus Atezolizumab for NSCLC
January 7th 2021The FDA has granted a breakthrough therapy designation to tiragolumab for use in combination with atezolizumab (Tecentriq) in the frontline treatment of patients with metastatic non­–small cell lung cancer.
Read More
FDA Approves FoundationOne Liquid CDx for Breast, Ovarian, Lung Cancer Indications
October 28th 2020FDA approves FoundationOne Liquid CDx as a companion diagnostic for alpelisib in advanced or metastatic breast cancer, rucaparib in advanced ovarian cancer, and alectinib in a specific type of metastatic non–small cell lung cancer.
Read More
